Induction of vitamin D receptor mRNA expression in psoriatic plaques correlates with clinical response to 1,25-dihydroxyvitamin D3

Journal of Investigative Dermatology

Volumn 106, Issue 4, 1996, Pages 637-641

  Chen, Ming L ^a   Perez, Alberto ^a   Sanan, Deepak K ^a   Heinrich, Gerhard ^a   Chen, Tai C ^a   Holick, Michael F ^a,b  

^a Abdominal Imaging   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

1 ,25 dihydroxyvitamin D3; Keratinocyte; Psoriasis; Skin; Vitamin D receptor

Indexed keywords

CALCITRIOL; MESSENGER RNA; PLACEBO; VITAMIN D RECEPTOR;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; HUMAN; KERATINOCYTE; PRIORITY JOURNAL; PSORIASIS; TOPICAL DRUG ADMINISTRATION;

EID: 0029877406     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/1523-1747.ep12345443     Document Type: Article

References (43)

1. 3 of cultured psoriatic epidermal keratinocytes isolated from involved and uninvolved skin. J Clin Endocrinol Metab 68:851-854, 1989
2. Baadsgaard O, Fisher G, Voorhees JJ, Cooper KD: The role of immune system in the pathogenesis of psoriasis. J Invest Dermatol 95:32S-34S, 1990
3. Baker AR, McDonnell DP, Hushes M, Crisp T, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW: Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85:3294-3298, 1988
4. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KC: Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. J Clin Invest 95:317-327, 1995
5. Bikle DD, Gee E, Pillai S: Regulation of keratinocyte growth, differentiation, and vitamin D metabolism by analogs of 1,25-dihydroxyvitamin D. J Invest Dermatol 101:713-718, 1993
6. Bourke JF, Berth-Jones J, Iqbal SJ, Hutchinson PE: High-dose topical calcipotriol in the treatment of extensive psoriasis vulgaris. Br J Dermatol 129:74-76, 1993
7. Carlberg C, Bendik I, Wyss A, Meler E, Sturzenbecker LJ, Grippo JF, Hunziker W: Two nuclear signalling pathways for vitamin D. Nature 361:657-660, 1993
8. 3-24-hydroxylase mRNA in cultured human keratinocytes. Proc Soc Expet Biol Med 207:57-61, 1994
9. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chlorofurm extraction. Anal Biochem 162:156-159, 1987
10. Darwish H, DeLuca HF: Vitamin D-regulated gene expression. Crit Rev Eurkaryot Gene Exp 3:89-116, 1993
11. Ercolan L, Florence B, Denaro M, Alexander M: Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 263:15335-15341, 1988
12. Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb AB: Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human kerarinocytes. Proc Natl Acad Sd USA 86:6367-6371, 1989
13. 3, MC903, and their analogues herald a new pharmacologic era for the treatment of psoriasis? Arch Dermatol 125:1692-1696, 1989
14. Holick MF: Active vitamin D compounds and analogues: a new therapeutic era for dermatology in the 21sr century. Mayo Clin Proc 68:925-927, 1993
15. Hughes MK, Malloy PJ, Kieback DG, Kesterson RA, Pike JW, Feldman D, O'Malley BW: Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. Science 242:1702-1705, 1988
16. Kragballe K: Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC 903). Arch Dermatol 125:1647-1652, 1989
17. Kragballe K, Gjertsen B, DeHoop D, Karlsmark T, van De Kerkhof P, Larko O: Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 337:193-196, 1991
18. 3 receptors by parathyroid hormone in osteoblastic cells: role of second messenger pathways. Endocrinology 136, 705-712, 1995
19. Krishnan AV, Feldman D: Stimulation of 1,25-dihydroxyvitamin D, receptor gene expression in cultured cells by serum and growth factors. J Bone Miner Res 6:1099-1107, 1991
20. 3 receptor gene expression and enhances hormone action. Mol Endocrinol 6:198-206, 1992
21. Krueger JG, Krane JF, Carter DM, Gottlieb AB: Role of growth factors, cytokines, and their receptors in the pathogenesis of psoriasis. J Invest Dermatol 94:135S-140S, 1990
22. Langner A, Verjans H, Stapor V, Mol M, Fraczykowksa M: Topical calcitriol in the treatment ot chronic plaque psoriasis: a double-blind study. Br J Dermatol 128:566-571, 1993
23. 3. Proc Natl Acad Sci USA 82:5409-5412, 1985
24. 3 in the growth and differentiation of human keratinocytes. Biochim Biophys Acta 1092: 311-318, 1991
25. 3 on normal human keratinocytes cultured in serum-free medium. Biochem Biophys Res Commun 166:916-923, 1990
26. 3 receptors in normal and psoriatic skin. J Invest Dermatol 97:230-239, 1991
27. 3-mediated gene regulation in human B lymphocytes. J Biol Chem 269:13437-13443, 1994
28. Morrison NA, Yeoman R, Kelly PJ, Eisman JA: Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA 89:6665-6669, 1992
29. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA: Prediction of bone density from vitamin D receptor alleles. Nature 367:284-287, 1994
30. 3-24-hydroxylase in rat osteoblasts. Endocrinology 134:1794-1799, 1994
31. Paludan K, Thestrup-Pedersen K: Use of the polymerase chain reaction in quantification of interleukin 8 mRNA in minute epidermal samples. J Invest Dermatol 99:830-835, 1992
32. 3. J Cellul Physiol 146:94-100, 1991
33. 3 inhibits γ-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA 84:3385-3389, 1987
34. 3 mRNA in human breast cancer tissue by polymerase chain reaction and in rat mammary tumors by northern blots. In: Norman AW, Bouillon R, Thomasset M, (eds.). Vitamin D - Gene Regulation, Structure-Function Analysis and Clinical Application. Walter de Gruyter press. 1991, pp 459-460
35. Smith EL, Pincus SH, Donovan L, Holick MF: A novel approach for the evaluation and treatment of psoriasis. J Am Acad Dermatol 19:516-528, 1988
36. 3 on the morphological and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 86:709-714, 1986
37. 3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) posttranscriptionally. J Clin Invest 81:1819-1823, 1988
38. 3: a novel immunoregulatory hormone. Science 224:1438-1439, 1984
39. 3. J Clin Endocrinol Metab 69:127-133, 1989
40. Vollmer S, Menssen A, Trommler P, Schendel D, Prinz JC: T-lymphocytes derived from skin lesions of patients with psoriasis vulgaris express a novel cytokine pattern that is distinct from that of T helper type 1 and T helper type 2 cells. Eur J Immunol 24:2377-2382, 1994
41. 3 results from ligand-induced stabilization. J Biol Chem 267:20082-20086, 1992
42. Yu XP, Mocharla H, Hustmyer FG, Manolagas SC: Vitamin D receptor expression in human lymphocytes. J Biol Chem 266:7588-7595, 1991
43. Zhao X, Feldman D: Regulation of vitamin D receptor abundance and responsiveness during differentiation of HT-29 human colon cancer cells. Endocrinology 132: 1808-1814, 1993